Cargando…

Evaluation of mortality risk after COVID-19 vaccination, Utah 2021

INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between...

Descripción completa

Detalles Bibliográficos
Autores principales: Payne, Jessica R., Bose, Srimoyee, Kubiak, Rachel W., Nolen, Leisha D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073592/
https://www.ncbi.nlm.nih.gov/pubmed/37037710
http://dx.doi.org/10.1016/j.vaccine.2023.03.072
_version_ 1785019605352185856
author Payne, Jessica R.
Bose, Srimoyee
Kubiak, Rachel W.
Nolen, Leisha D.
author_facet Payne, Jessica R.
Bose, Srimoyee
Kubiak, Rachel W.
Nolen, Leisha D.
author_sort Payne, Jessica R.
collection PubMed
description INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between December 18, 2020 and December 31, 2021 to Utah’s 2021 vital statistics death records. Vaccinated people were categorized as having one, two, or ≥ three COVID-19 vaccine doses in a time-updated metric. We examined crude mortality rates by dosing groups in two-week intervals for all deaths, and by COVID-19 versus non-COVID-19 causes, within the 44 weeks following receipt of the most recent vaccine. RESULTS: We identified 2,072,908 individuals who received at least one dose of COVID-19 vaccine of whom 10,997 died in 2021. Only 17.5 % of the total vaccinated population was age 65+, while 80.9 % of those who died were over 65. In the four weeks following the first or second vaccination, all-cause mortality was low and then stabilized for the remainder of the evaluation period at a bi-weekly average of 33.0 and 39.0 deaths/100,000 people for one and two doses, respectively. Typical seasonal variation in death was observed among those with two doses. Small sample size precluded analysis of those with ≥ three doses, but trends were similar. CONCLUSIONS: Mortality rates in the 44 weeks following the COVID-19 vaccination did not show trends suggesting an increase in mortality related to COVID-19 vaccination, reinforcing the safety of COVID-19 vaccines. This represents an accessible approach for local evaluation.
format Online
Article
Text
id pubmed-10073592
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100735922023-04-05 Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 Payne, Jessica R. Bose, Srimoyee Kubiak, Rachel W. Nolen, Leisha D. Vaccine Article INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between December 18, 2020 and December 31, 2021 to Utah’s 2021 vital statistics death records. Vaccinated people were categorized as having one, two, or ≥ three COVID-19 vaccine doses in a time-updated metric. We examined crude mortality rates by dosing groups in two-week intervals for all deaths, and by COVID-19 versus non-COVID-19 causes, within the 44 weeks following receipt of the most recent vaccine. RESULTS: We identified 2,072,908 individuals who received at least one dose of COVID-19 vaccine of whom 10,997 died in 2021. Only 17.5 % of the total vaccinated population was age 65+, while 80.9 % of those who died were over 65. In the four weeks following the first or second vaccination, all-cause mortality was low and then stabilized for the remainder of the evaluation period at a bi-weekly average of 33.0 and 39.0 deaths/100,000 people for one and two doses, respectively. Typical seasonal variation in death was observed among those with two doses. Small sample size precluded analysis of those with ≥ three doses, but trends were similar. CONCLUSIONS: Mortality rates in the 44 weeks following the COVID-19 vaccination did not show trends suggesting an increase in mortality related to COVID-19 vaccination, reinforcing the safety of COVID-19 vaccines. This represents an accessible approach for local evaluation. Elsevier Ltd. 2023-05-02 2023-04-05 /pmc/articles/PMC10073592/ /pubmed/37037710 http://dx.doi.org/10.1016/j.vaccine.2023.03.072 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Payne, Jessica R.
Bose, Srimoyee
Kubiak, Rachel W.
Nolen, Leisha D.
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title_full Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title_fullStr Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title_full_unstemmed Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title_short Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
title_sort evaluation of mortality risk after covid-19 vaccination, utah 2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073592/
https://www.ncbi.nlm.nih.gov/pubmed/37037710
http://dx.doi.org/10.1016/j.vaccine.2023.03.072
work_keys_str_mv AT paynejessicar evaluationofmortalityriskaftercovid19vaccinationutah2021
AT bosesrimoyee evaluationofmortalityriskaftercovid19vaccinationutah2021
AT kubiakrachelw evaluationofmortalityriskaftercovid19vaccinationutah2021
AT nolenleishad evaluationofmortalityriskaftercovid19vaccinationutah2021